HendersonLACannaSWFriedmanKG, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: Version 1. Arthritis Rheumatol. 2020;72:1791-1805. doi:10.1002/art.41454
3.
PerkinsGDCouperKConnollyB, et al. RECOVERY-respiratory support: respiratory strategies for patients with suspected or proven COVID-19 respiratory failure; continuous positive airway pressure, high-flow nasal oxygen, and standard care: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:687. doi:10.1186/s13063-020-04617-3
4.
JennetteJCFalkRJBaconPA, et al. 2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1-11. doi:10.1002/art.37715
5.
PiramMMahrA. Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge. Curr Opin Rheumatol. 2013;25:171-178. doi:10.1097/BOR.0b013e32835d8e2a
6.
Gardner-MedwinJMMDolezalovaPCumminsCSouthwoodTR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197-1202. doi:10.1016/S0140-6736(02)11279-7
7.
MillsJAMichelBABlochDA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990;33:1114-1121. doi:10.1002/art.1780330809
8.
WeiLYLiuCZhangYLLiGL. IgA nephropathy with leucocytoclastic vasculitis. J Int Med Res. 2018;46:3009-3014. doi:10.1177/0300060518775814
RiganteDCastellazziLBoscoAEspositoS. Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura?Autoimmun Rev. 2013;12:1016-1021. doi:10.1016/j.autrev.2013.04.003
11.
WeissPFKlinkAJLuanXFeudtnerC. Temporal association of Streptococcus, Staphylococcus, and parainfluenza pediatric hospitalizations and hospitalized cases of Henoch-Schönlein purpura. J Rheumatol. 2010;37:2587-2594. doi:10.3899/jrheum.100364
12.
RadiaTWilliamsNAgrawalP, et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): a systematic review of clinical features and presentation. Paediatr Respir Rev. 2021;38:51-57. doi:10.1016/j.prrv.2020.08.001
13.
WhittakerEBamfordAKennyJ, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 group information. JAMA. 2020;324:259-269. doi:10.1001/jama.2020.10369
14.
World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief, 15 May 2020. Accessed August 5, 2021. https://apps.who.int/iris/handle/10665/332095
AlghooziDAAlkhayyatHM. A child with Henoch-Schonlein purpura secondary to a COVID-19 infection. BMJ Case Rep. 2021;14:239910. doi:10.1136/bcr-2020-239910
17.
JacobiMLancreiHMBrosh-NissimovTYeshayahuY. Purpurona: a novel report of COVID-19-related Henoch-Schonlein purpura in a child. Pediatr Infect Dis J. 2021;40:e93-e94. doi:10.1097/INF.0000000000003001
18.
HoskinsBKeevenNDangMKellerENagpalR. A child with covid-19 and immunoglobulin a vasculitis. Pediatr Ann. 2021;50:e44-e48. doi:10.3928/19382359-20201211-01
